PT-141 (Bremelanotide) vs Melanotan-II
Dosing, half-life, mechanism, benefits, and safety — side by side.
PT-141 (Bremelanotide)
FDA ApprovedMelanocortin receptor agonist FDA-approved for sexual dysfunction
Half-Life
Variable
Route
SC
Dose
1.75 mg PRN
MW
1025.18 Da
Melanotan-II
FDA ApprovedMelanocortin receptor agonist for tanning and appetite suppression
Half-Life
~1 hour
Route
SC
Dose
0.5-1 mg Loading then maintenance
MW
1024.0 Da
Quick Reference
| PT-141 (Bremelanotide) | Melanotan-II | |
|---|---|---|
| Category | N/A | N/A |
| Route | SC | SC |
| Typical Dose | 1.75 mg PRN | 0.5-1 mg Loading then maintenance |
| Frequency | N/A | N/A |
| FDA Approved | Yes | Yes |
| WADA Status | Not banned | Not banned |
⏱ Pharmacokinetics
| PT-141 (Bremelanotide) | Melanotan-II | |
|---|---|---|
| Half-Life | Variable | ~1 hour |
| Research Status | N/A | N/A |
| CAS Number | 189691-06-3 | 121062-08-6 |
Molecular
| PT-141 (Bremelanotide) | Melanotan-II | |
|---|---|---|
| Molecular Weight | 1025.18 | 1024.0 |
| Molecular Formula | C50H68N14O10 | C50H69N15O9 |
| Sequence Length | 42 aa | 125 aa |
| Mechanism | Melanocortin receptor agonist | Melanocortin receptor agonist for tanning |
Key Benefits
| PT-141 (Bremelanotide) | Melanotan-II | |
|---|---|---|
| Benefits | FDA-approved libido enhancement; Sexual desire boost; Central nervous system activation; Effective in premenopausal women; Non-hormonal approach; Clinically proven efficacy; HSDD Treatment: Significant improvement in desire/distress scores; Significant improvement in sexual desire (FSFI scale) | Penile erection in 17/20 men without sexual stimulation; Increased sexual desire; Weight loss and fat reduction; Tanning/skin pigmentation; Tanning without UV exposure; Erectile function enhancement; Appetite suppression |
Safety & Warnings
| PT-141 (Bremelanotide) | Melanotan-II | |
|---|---|---|
| Safety Note | FDA-approved with established safety profile. Common side effects include nausea and flushing. | ⚠️⚠️ ILLEGAL - NOT APPROVED in any jurisdiction. Multiple national health warnings issued. NO SAFE PROTOCOL. Associated with priapism and melanocytic changes. |
| Side Effects | Nausea (39.9%, common); Facial flushing (20.4%); Headache (11%); Blood pressure increase; Facial flushing; BP increase; Mild-Moderate side effect; Mild-Moderate side effect | Nausea (12.9% severe at 0.025 mg/kg); Facial flushing; Yawning; Priapism (case reports); Nausea; Facial flushing; Melanocytic changes; NOT APPROVED - health warnings |
| Athlete Warning | Not WADA banned - antioxidant supplement safe for competitive athletes | N/A |
Which should you choose?
Both PT-141 (Bremelanotide) and Melanotan-II have meaningful research support. The right choice depends on your specific goals, tolerance, and whether an FDA-approved option fits your needs.
PT-141 (Bremelanotide) vs Melanotan-II — FAQ
Which has a longer half-life: PT-141 (Bremelanotide) or Melanotan-II?
PT-141 (Bremelanotide) has a half-life of ~Variable while Melanotan-II has a half-life of ~~1 hour. A longer half-life generally means less frequent dosing and more stable levels.
Can I stack PT-141 (Bremelanotide) and Melanotan-II together?
Whether PT-141 (Bremelanotide) and Melanotan-II can be stacked depends on their mechanisms and receptor targets. Use the stack compatibility checker to analyze synergies and conflicts before combining any peptides.
Which is better: PT-141 (Bremelanotide) or Melanotan-II?
There is no universal "better" peptide — it depends on your goal. PT-141 (Bremelanotide) is Melanocortin receptor agonist. Melanotan-II is Melanocortin receptor agonist for tanning. Choose based on your primary goal and research profile.
More Comparisons
Tirzepatide vs Semaglutide
Compare side-by-side →
BPC-157 vs TB-500
Compare side-by-side →
Retatrutide vs Tirzepatide
Compare side-by-side →
Semaglutide vs Retatrutide
Compare side-by-side →
Ipamorelin vs Sermorelin
Compare side-by-side →
CJC-1295 vs Sermorelin
Compare side-by-side →
MK-677 vs Ipamorelin
Compare side-by-side →
GHK-Cu vs AHK-Cu
Compare side-by-side →
Selank vs Semax
Compare side-by-side →
MOTS-c vs NAD+
Compare side-by-side →
Tesamorelin vs CJC-1295
Compare side-by-side →
HGH vs MK-677
Compare side-by-side →
Semaglutide vs Liraglutide
Compare side-by-side →